These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21430706)

  • 1. Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action.
    Meissner M; Doll M; Hrgovic I; Reichenbach G; König V; Hailemariam-Jahn T; Gille J; Kaufmann R
    J Invest Dermatol; 2011 Jun; 131(6):1356-64. PubMed ID: 21430706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
    Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
    Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner.
    Meissner M; Hrgovic I; Doll M; Kaufmann R
    Arch Dermatol Res; 2011 Jan; 303(1):41-7. PubMed ID: 21046127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect?
    García-Caballero M; Marí-Beffa M; Medina MÁ; Quesada AR
    J Invest Dermatol; 2011 Jun; 131(6):1347-55. PubMed ID: 21289642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
    Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
    Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
    Dardik R; Livnat T; Seligsohn U
    Thromb Haemost; 2009 Nov; 102(5):975-82. PubMed ID: 19888537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade.
    Shen K; Ji L; Lu B; Xu C; Gong C; Morahan G; Wang Z
    Chem Biol Interact; 2014 Jul; 218():99-106. PubMed ID: 24814888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
    Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.
    Saraswati S; Agrawal SS
    Cancer Lett; 2013 May; 332(1):83-93. PubMed ID: 23348691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
    Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
    Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study for anti-angiogenic activities of polysaccharides isolated from Antrodia cinnamomea in endothelial cells.
    Cheng JJ; Huang NK; Chang TT; Wang DL; Lu MK
    Life Sci; 2005 May; 76(26):3029-42. PubMed ID: 15850596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor-2 inhibition in experimental murine colitis.
    Knod L; Donovan EC; Chernoguz A; Crawford KM; Dusing MR; Frischer JS
    J Surg Res; 2013 Sep; 184(1):101-7. PubMed ID: 23688787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
    Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
    Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J; Huang S; Armstrong EA; Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
    Kou R; SenBanerjee S; Jain MK; Michel T
    Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth.
    Wicki A; Rochlitz C; Orleth A; Ritschard R; Albrecht I; Herrmann R; Christofori G; Mamot C
    Clin Cancer Res; 2012 Jan; 18(2):454-64. PubMed ID: 22065082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.